Real-World Evidence in Medical Product Development

This book provides state-of-art statistical methodologies, practical considerations from regulators and sponsors, logistics, and real use cases for practitioners for the uptake of RWE/D. Randomized clinical trials have been the gold standard for the evaluation of efficacy and safety of medical produ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Coauteur: SpringerLink (Online service)
Andere auteurs: He, Weili (Redacteur), Fang, Yixin (Redacteur), Wang, Hongwei (Redacteur)
Formaat: Elektronisch E-boek
Taal:Engels
Gepubliceerd in: Cham : Springer International Publishing : Imprint: Springer, 2023.
Editie:1st ed. 2023.
Onderwerpen:
Online toegang:https://doi.org/10.1007/978-3-031-26328-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-26328-6
003 DE-He213
005 20251113181535.0
007 cr nn 008mamaa
008 230511s2023 sz | s |||| 0|eng d
020 |a 9783031263286  |9 978-3-031-26328-6 
024 7 |a 10.1007/978-3-031-26328-6  |2 doi 
050 4 |a QA276-280 
072 7 |a PBT  |2 bicssc 
072 7 |a MAT029000  |2 bisacsh 
072 7 |a PBT  |2 thema 
082 0 4 |a 519.5  |2 23 
245 1 0 |a Real-World Evidence in Medical Product Development  |h [electronic resource] /  |c edited by Weili He, Yixin Fang, Hongwei Wang. 
250 |a 1st ed. 2023. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2023. 
300 |a XXVII, 417 p. 1 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preface -- Part I. Real-World Data and Evidence to Accelerate Medical Product Development -- The need for real world data/evidence in clinical development and life cycle management, and future directions -- Overview of current RWE/RWD landscape -- Key considerations in forming research questions -- Part II. Fit-for-use RWD Assessment and Data Standards -- Assessment of fit-for-use real-world data sources and applications -- Key variables ascertainment and validation in real-world setting -- Data standards and platform interoperability -- Privacy-preserving data linkage for real-world datasets -- Part III. Causal Inference Framework and Methodologies in RWE Research -- Causal Inference with Targeted Learning for Producing and Evaluating Real-World Evidence -- Framework and Examples of Estimands in Real-World Studies -- Clinical Studies Leveraging Real-World Data Using Propensity Score-Based Methods -- Recent statistical development for comparative effectiveness research beyond propensity-score methods -- Innovative Hybrid Designs and Analytical Approaches leveraging Real-Word Data and Clinical Trial data -- Statistical challenges for causal inference using time-to-event real-world data -- Sensitivity Analyses for Unmeasured Confounding: This is the way -- Sensitivity analysis in the analysis of real-world data -- Personalized medicine with advanced analytics -- Use of Real-World Evidence in Health Technology Assessment Submissions -- Part IV. Application and Case studies -- Examples of applying causal-inference roadmap to real-world studies -- Applications using real-world evidence to accelerate medical product development -- The use of real-world data to support the assessment of the benefit and risk of a medicine to treat spinal muscular atrophy -- Index. 
520 |a This book provides state-of-art statistical methodologies, practical considerations from regulators and sponsors, logistics, and real use cases for practitioners for the uptake of RWE/D. Randomized clinical trials have been the gold standard for the evaluation of efficacy and safety of medical products. However, the cost, duration, practicality, and limited generalizability have incentivized many to look for alternative ways to optimize drug development. This book provides a comprehensive list of topics together to include all aspects with the uptake of RWE/D, including, but not limited to, applications in regulatory and non-regulatory settings, causal inference methodologies, organization and infrastructure considerations, logistic challenges, and practical use cases. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
650 0 |a Statistics . 
650 0 |a Artificial intelligence  |x Data processing. 
650 0 |a Computer science  |x Mathematics. 
650 1 4 |a Statistics. 
650 2 4 |a Data Science. 
650 2 4 |a Mathematics of Computing. 
700 1 |a He, Weili.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Fang, Yixin.  |e editor.  |0 (orcid)0000-0001-9129-5358  |1 https://orcid.org/0000-0001-9129-5358  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Wang, Hongwei.  |e editor.  |0 (orcid)0000-0003-1211-1966  |1 https://orcid.org/0000-0003-1211-1966  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031263279 
776 0 8 |i Printed edition:  |z 9783031263293 
776 0 8 |i Printed edition:  |z 9783031263309 
856 4 0 |u https://doi.org/10.1007/978-3-031-26328-6 
912 |a ZDB-2-SMA 
912 |a ZDB-2-SXMS 
950 |a Mathematics and Statistics (SpringerNature-11649) 
950 |a Mathematics and Statistics (R0) (SpringerNature-43713)